BZYR logo

Burzynski Research Institute, Inc. Stock Price

OTCPK:BZYR Community·US$4.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

BZYR Share Price Performance

US$0.033
-0.02 (-34.00%)
US$0.033
-0.02 (-34.00%)
Price US$0.033

BZYR Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with worrying balance sheet.

6 Risks
0 Rewards

Burzynski Research Institute, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$1.3m

Other Expenses

-US$1.3m

Earnings

Last Reported Earnings
Aug 31, 2025
Next Reporting Earnings
n/a
-0.01
0%
0%
0%
View Full Analysis

About BZYR

Founded
1977
Employees
n/a
CEO
Stanislaw Burzynski
WebsiteView website
propcitweb.ddns.net:83

Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.

Recent BZYR News & Updates

No updates

Recent updates

No updates